[1] 郭泰,宣雯霞,毕树雄.膝骨关节炎的治疗进展[J].中国药物与临床,2014,14(3):330-332.
[2] 李永忠,闵华,刘超,等.骨关节炎疾病中白细胞介素17协同肿瘤坏死因子a调节诱导型一氧化氮合酶的表达[J].中国组织工程研究,2012,16(24):4393-4397.
[3] 罗玉明,郑维篷,魏合伟.骨关节炎与细胞因子TNF-α,IL-6 关系的研究进展[J].现代诊断与治疗,2013,24(2): 326-327.
[4] 王秀华.补肾法对老年膝骨性关节炎患者TNF-α的影响[J].中医药学报, 2013,41(3): 24-125.
[5] 程圆圆,刘健,冯云霞,等.基于TGF-1及其Smad 信号转导探讨膝骨关节炎大鼠肺功能下降的机制[J].时珍国医国药, 2013,24(4):993-996.
[6] 鲁彪,蒋青.IGF-1 在骨性关节炎中的研究进展[J].江苏医药,2011,37(14):1700-1702.
[7] 张艳玲,武永利,闫安,等.温针灸对膝骨性关节炎患者血清中IGF-1,TGF-β 和FGF-2 表达水平影响的研究[J].宁夏医科大学学报,2013,32(5):177-180.
[8] 霍红军,王维山,董金波,等.骨性关节炎患者不同病变程度滑膜中基质金属蛋白酶-3的表达及意义[J].实用医学杂志, 2014,30(6):895-897.
[9] Chao PZ, Hsieh MS, Cheng CW, et al. Regulation of MMP-3 expression and secretion by the chemokine eotaxin-1 in human chondrocytes. J Biomed Sci. 2011; 18:86.
[10] 贺占坤,沈杰威.MMP-2,MMP-3,MMP-9 和TIMP-1评价膝关节骨性关节炎的临床研究[J].重庆医学,2013, 32(4): 3872-3874.
[11] Velasquez MT, Katz JD. Osteoarthritis: another component of metabolic syndrome. Metab Syndr Relat Disord. 2010;8(4):295-305.
[12] Kapoor M, Martel-Pelletier J, Lajeunesse D, et al. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol. 2011;7(1):33-42.
[13] Tögel F, Hu Z, Weiss K, et al. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol. 2005; 289(1):F31-42.
[14] 李小峰.重视类风湿关节炎发病机制及治疗的研究进展[J].中华风湿病学杂志,2008, 12(1):1-3.
[15] Sampson S, Botto-van Bemden A, Aufiero D. Autologous bone marrow concentrate: review and application of a novel intra-articular orthobiologic for cartilage disease. Phys Sportsmed. 2013;41(3):7-18.
[16] Mabuchi Y, Houlihan DD, Akazawa C, et al. Prospective isolation of murine and human bone marrow mesenchymal stem cells based on surface markers. Stem Cells Int. 2013;2013:507301.
[17] Orozco L, Munar A, Soler R, et al. Treatment of knee osteoarthritis with autologous mesenchymal stem cells: a pilot study. Transplantation. 2013;95(12):1535-1541.
[18] Buda R, Vannini F, Cavallo M, et al. One-step arthroscopic technique for the treatment of osteochondral lesions of the knee with bone-marrow-derived cells: three years results. Musculoskelet Surg. 2013;97(2):145-151.
[19] 许键炜,申长清,赵芳芳,等.骨髓间充质干细胞对大鼠佐剂性关节炎防治的实验研究[J].重庆医学,2013,42(29): 3472-3475.
[20] Punwar S, Khan WS. Mesenchymal stem cells and articular cartilage repair: clinical studies and future direction. Open Orthop J. 2011;5 Suppl 2:296-301.
[21] Al Faqeh H, Nor Hamdan BM, Chen HC, et al. The potential of intra-articular injection of chondrogenic-induced bone marrow stem cells to retard the progression of osteoarthritis in a sheep model. Exp Gerontol. 2012;47(6):458-464.
[22] 杨爱成,林辉遂,李杰峰,等.间充质干细胞治疗类风湿关节炎的研究进展[J].风湿病与关节炎,2013,2(7):67-71.
[23] Le Blanc K, Ringdén O. Immunomodulation by mesenchymal stem cells and clinical experience. J Intern Med. 2007;262(5):509-525.
[24] Ozaki K, Sato K, Oh I, et al. Mechanisms of immunomodulation by mesenchymal stem cells. Int J Hematol. 2007;86(1):5-7.
[25] Fibbe WE, Nauta AJ, Roelofs H. Modulation of immune responses by mesenchymal stem cells. Ann N Y Acad Sci. 2007;1106:272-278.
[26] Uccelli A, Pistoia V, Moretta L. Mesenchymal stem cells: a new strategy for immunosuppression. Trends Immunol. 2007;28(5):219-226. |